This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Metabasis Therapeutics, Inc., Viking Therapeutics, Inc., Quatrx Pharmaceuticals. Active years: 2019-2025.
Company Filing History:
3 out of 64 
3 out of 13 
1 out of 2 Years Active: 2019-2025
Title: Innovator Rochelle Hanley: Pioneering Advances in Medical Treatments
Introduction
Rochelle Hanley, an esteemed inventor based in Ann Arbor, MI, has made significant contributions to the field of medical treatments through her valuable patents. With a total of three patents to her name, Hanley is recognized for her innovative work, particularly in treating rare diseases.
Latest Patents
Among her latest patents is a groundbreaking method involving the use of thyroid beta-agonists, which are instrumental in treating X-linked adrenoleukodystrophy. This condition is a serious genetic disorder, and her inventive approach offers new avenues for effective management and treatment.
Career Highlights
Throughout her career, Hanley has worked with notable companies such as Viking Therapeutics and Metabasis Therapeutics. Her expertise and dedication have positioned her as a leading figure in her field, focusing on innovative solutions in medical therapies.
Collaborations
Rochelle has collaborated with esteemed colleagues, including Brian Lian and Misha Dinerman. Together, they have contributed to advancements in medical research, harnessing their collective expertise to develop innovative treatments.
Conclusion
Rochelle Hanley's contributions to the medical field exemplify the essence of innovation. Through her patents and collaborative efforts, she continues to pave the way for new treatments that offer hope to individuals affected by challenging conditions. Her commitment to advancing healthcare underscores the vital role of inventors in shaping the future.